Latest Regional Growth News

QMines Limited has launched a significant 5,000m drilling campaign at its Mount Mackenzie gold and silver project, aiming to unlock substantial resource growth potential following a recent resource upgrade.

InFocus Group Holdings has locked in up to AUD 1.7 million in potential revenues through new contracts in healthcare and logistics, underpinning its operational expansion in Southeast Asia.

Barton Gold Holdings has upgraded its Challenger Gold Project resource to over 300,000 ounces of gold and is advancing feasibility studies targeting production by the end of 2026. The company plans a phased approach starting with tailings reprocessing before fresh rock mining.

Austral Resources has finalized key agreements with Glencore, including tolling, loan, and offtake contracts, paving the way for its acquisition of the Rocklands copper project and expanding its footprint in Queensland.

Castle Minerals has initiated a focused auger drilling campaign at its Kandia Gold Project in Ghana, aiming to extend known mineralised zones and explore new targets identified through advanced aeromagnetic data. The company also plans a similar campaign at Kpali and is pursuing a strategic acquisition in Côte d’Ivoire to broaden its West African footprint.

Waterco Limited reported a 4% increase in FY25 sales revenue to $249.4 million, driven by regional growth and integration benefits from the Davey acquisition. Despite revenue gains, earnings declined due to cost pressures and restructuring, with statutory NPAT down 31%.

Gale Pacific’s FY25 results reveal resilience amid US market challenges, with growth in Australia and the Middle East offsetting tariff impacts and prompting a major US operating restructure.

RAS Technology Holdings reports a robust 31% revenue increase in FY25, marking its second consecutive profitable year, driven by strategic acquisitions and global partnerships that position it for sustained growth.

SomnoMed has delivered a standout FY25 with revenue and EBITDA exceeding market expectations, driven by strong regional growth and operational improvements. The company is now expanding capacity and advancing its innovative Rest Assure device.

SomnoMed Limited reported a record FY25 with $111.5 million revenue and a return to positive EBITDA, marking a milestone of over one million patients treated globally. The company secured FDA clearance for its Rest Assure® compliance tracking device and provided optimistic guidance for FY26.

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.